Literature DB >> 30875636

Metastasis suppressor NME1 promotes non-homologous end joining of DNA double-strand breaks.

Renyu Xue1, Yihan Peng2, Baolin Han3, Xiangpan Li4, Yali Chen5, Huadong Pei6.   

Abstract

NME1 (also known as NM23-H1) was the first identified tumor metastasis suppressor, which has been reported to link with genomic stability maintenance and cancer. However its underlying mechanisms are still not fully understood. Here we find that NME1 is required for non-homologous end joining (NHEJ) of DNA double-strand breaks (DSBs). Mechanistically, NME1 re-localizes to DNA damage sites in a Ku-XRCC4-dependent manner, and regulates downstream LIG4 recruitment and end joining efficiency. Furthermore, we show that the 3'-5' exonuclease activity of NME1 is critical for its function in NHEJ. Taken together, our findings identify NME1 as a novel NHEJ factor, and reveal how this metastasis suppressor promotes genome stability.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3′-5′ exonuclease; DNA double-strand breaks; Genomic stability; NHEJ; NME1

Year:  2019        PMID: 30875636     DOI: 10.1016/j.dnarep.2019.03.003

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  9 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  NDK/NME proteins: a host-pathogen interface perspective towards therapeutics.

Authors:  Ankit Gupta; Krishna Murari Sinha; Malik Z Abdin; Niti Puri; Angamuthu Selvapandiyan
Journal:  Curr Genet       Date:  2021-09-03       Impact factor: 3.886

Review 3.  Non-translational Connections of eEF1B in the Cytoplasm and Nucleus of Cancer Cells.

Authors:  Boris Negrutskii
Journal:  Front Mol Biosci       Date:  2020-04-09

4.  Metastasis Suppressor NME1 Modulates Choice of Double-Strand Break Repair Pathways in Melanoma Cells by Enhancing Alternative NHEJ while Inhibiting NHEJ and HR.

Authors:  Gemma Puts; Stuart Jarrett; Mary Leonard; Nicolette Matsangos; Devin Snyder; Ying Wang; Richard Vincent; Benjamin Portney; Rachel Abbotts; Lena McLaughlin; Michal Zalzman; Feyruz Rassool; David Kaetzel
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

5.  Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.

Authors:  M Kathryn Leonard; Gemma S Puts; Nidhi Pamidimukkala; Gautam Adhikary; Yili Xu; Eric Kwok; Yuxin Jin; Devin Snyder; Nicolette Matsangos; Marián Novak; Anup Mahurkar; Amol C Shetty; Radomir M Slominski; Edward C De Fabo; Frances P Noonan; Chi-Ping Day; Mohammed Rigi; Andrzej T Slominski; Michelle G Webb; David W Craig; Glenn Merlino; Richard L Eckert; John D Carpten; Zarko Manojlovic; David M Kaetzel
Journal:  Oncogene       Date:  2021-08-25       Impact factor: 9.867

6.  A genome-wide screen uncovers multiple roles for mitochondrial nucleoside diphosphate kinase D in inflammasome activation.

Authors:  Orna Ernst; Jing Sun; Bin Lin; Balaji Banoth; Michael G Dorrington; Jonathan Liang; Benjamin Schwarz; Kaitlin A Stromberg; Samuel Katz; Sharat J Vayttaden; Clinton J Bradfield; Nadia Slepushkina; Christopher M Rice; Eugen Buehler; Jaspal S Khillan; Daniel W McVicar; Catharine M Bosio; Clare E Bryant; Fayyaz S Sutterwala; Scott E Martin; Madhu Lal-Nag; Iain D C Fraser
Journal:  Sci Signal       Date:  2021-08-03       Impact factor: 9.517

7.  The Subcellular Localization and Oligomerization Preferences of NME1/NME2 upon Radiation-Induced DNA Damage.

Authors:  Martina Radić; Marko Šoštar; Igor Weber; Helena Ćetković; Neda Slade; Maja Herak Bosnar
Journal:  Int J Mol Sci       Date:  2020-03-29       Impact factor: 5.923

8.  Comprehensive analysis of the NME gene family functions in breast cancer.

Authors:  Haoming Wu; Xinjian Huang; Siliang Chen; Siqi Li; Jikun Feng; Xiazi Zouxu; Zeming Xie; Xinhua Xie; Xi Wang
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

9.  Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer.

Authors:  Emre Ozoran; Fadime Didem Can Trabulus; Duygu Erhan; Bahadir Batar; Mehmet Guven
Journal:  Int J Breast Cancer       Date:  2022-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.